CN Patent

CN101695488A — 复方阿替卡因注射用冻干制剂及其制备方法

Assigned to Anhui BBCA Pharmaceutical Co Ltd · Expires 2010-04-21 · 16y expired

What this patent protects

本发明公开了一种复方阿替卡因注射用冻干制剂，其主要由主药盐酸阿替卡因、肾上腺素和辅药抗氧剂、等渗及pH调节剂、填充剂制成。本发明还提供了其制备方法。采用本发明提供的原辅料和制备方法制备出的复方阿替卡因注射用冻干制剂产品稳定性良好，常温放置6个月以上，溶解使用时溶液澄清度高，有效含量保留98％以上，适合临床使用。

USPTO Abstract

本发明公开了一种复方阿替卡因注射用冻干制剂，其主要由主药盐酸阿替卡因、肾上腺素和辅药抗氧剂、等渗及pH调节剂、填充剂制成。本发明还提供了其制备方法。采用本发明提供的原辅料和制备方法制备出的复方阿替卡因注射用冻干制剂产品稳定性良好，常温放置6个月以上，溶解使用时溶液澄清度高，有效含量保留98％以上，适合临床使用。

Drugs covered by this patent

Patent Metadata

Patent number
CN101695488A
Jurisdiction
CN
Classification
—
Expires
2010-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Anhui BBCA Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.